CytoSorbents Corp. (CTSO)
0.61
+0.01
(+0.84%)
USD |
NASDAQ |
Apr 10, 16:00
0.6135
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents EPS Diluted (Quarterly) : -0.0875 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Delcath Systems, Inc. | -0.052 |
| Quest Diagnostics, Inc. | 2.188 |
| Danaher Corp. | 1.684 |
| Cardiac Biotech Solutions, Inc. | -0.0035 |
| Odyssey Health, Inc. | -0.0334 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.497M |
| Revenue (Quarterly) | 9.234M |
| Total Expenses (Quarterly) | 14.73M |
| Enterprise Value | 61.38M |
| Gross Profit Margin (Quarterly) | 73.68% |
| Profit Margin (Quarterly) | -59.53% |
| Earnings Yield | -21.85% |
| Normalized Earnings Yield | -19.87 |